199 related articles for article (PubMed ID: 17133164)
1. The impact of a change in bacille Calmette-Guérin vaccine policy on tuberculosis incidence in children in Cape Town, South Africa.
Mahomed H; Kibel M; Hawkridge T; Schaaf HS; Hanekom WA; Iloni K; Michaels D; Workman L; Verver S; Geiter L; Hussey GD
Pediatr Infect Dis J; 2006 Dec; 25(12):1167-72. PubMed ID: 17133164
[TBL] [Abstract][Full Text] [Related]
2. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children.
Hesseling AC; Marais BJ; Gie RP; Schaaf HS; Fine PE; Godfrey-Faussett P; Beyers N
Vaccine; 2007 Jan; 25(1):14-8. PubMed ID: 16959383
[TBL] [Abstract][Full Text] [Related]
3. A cost-effectiveness analysis of universal versus selective immunization with Mycobacterium bovis bacille Calmette-Guérin in Finland.
Hersh AL; Tala-Heikkilä M; Tala E; Tosteson AN; Fordham von Reyn C
Int J Tuberc Lung Dis; 2003 Jan; 7(1):22-9. PubMed ID: 12701831
[TBL] [Abstract][Full Text] [Related]
4. Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children.
Hesseling AC; Rabie H; Marais BJ; Manders M; Lips M; Schaaf HS; Gie RP; Cotton MF; van Helden PD; Warren RM; Beyers N
Clin Infect Dis; 2006 Feb; 42(4):548-58. PubMed ID: 16421800
[TBL] [Abstract][Full Text] [Related]
5. High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies.
Hesseling AC; Cotton MF; Jennings T; Whitelaw A; Johnson LF; Eley B; Roux P; Godfrey-Faussett P; Schaaf HS
Clin Infect Dis; 2009 Jan; 48(1):108-14. PubMed ID: 19049436
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong.
Leung CC; Tam CM; Chan SL; Chan-Yeung M; Chan CK; Chang KC
Int J Tuberc Lung Dis; 2001 Aug; 5(8):717-23. PubMed ID: 11495262
[TBL] [Abstract][Full Text] [Related]
7. Age-related tuberculosis incidence and severity in children under 5 years of age in Cape Town, South Africa.
Moyo S; Verver S; Mahomed H; Hawkridge A; Kibel M; Hatherill M; Tameris M; Geldenhuys H; Hanekom W; Hussey G
Int J Tuberc Lung Dis; 2010 Feb; 14(2):149-54. PubMed ID: 20074404
[TBL] [Abstract][Full Text] [Related]
8. The impact of a change in infant BCG vaccination policy on adolescent TB incidence rates: A South African population-level cohort study.
Fack C; Wood R; Hatherill M; Cobelens F; Hermans S
Vaccine; 2022 Jan; 40(2):364-369. PubMed ID: 34872798
[TBL] [Abstract][Full Text] [Related]
9. The impact of changing BCG coverage on tuberculosis incidence in Swedish-born children between 1969 and 1989.
Romanus V; Svensson A; Hallander HO
Tuber Lung Dis; 1992 Jun; 73(3):150-61. PubMed ID: 1421348
[TBL] [Abstract][Full Text] [Related]
10. Surgical complications of bacille Calmette-Guérin (BCG) infection in HIV-infected children: time for a change in policy.
Karpelowsky JS; Alexander AG; Peek SD; Millar AJ; Rode H
S Afr Med J; 2008 Oct; 98(10):801-4. PubMed ID: 19115758
[TBL] [Abstract][Full Text] [Related]
11. Childhood tuberculosis and tuberculous meningitis: high incidence rates in the Western Cape of South Africa.
Berman S; Kibel MA; Fourie PB; Strebel PM
Tuber Lung Dis; 1992 Dec; 73(6):349-55. PubMed ID: 1292715
[TBL] [Abstract][Full Text] [Related]
12. Danish bacille Calmette-Guérin vaccine-induced disease in human immunodeficiency virus-infected children.
Hesseling AC; Schaaf HS; Hanekom WA; Beyers N; Cotton MF; Gie RP; Marais BJ; van Helden P; Warren RM
Clin Infect Dis; 2003 Nov; 37(9):1226-33. PubMed ID: 14557968
[TBL] [Abstract][Full Text] [Related]
13. TB vaccines. Study finds BCG efficacious in Central African Republic.
Vaccine Wkly; 1996 Jan; ():15-6. PubMed ID: 12346928
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic disseminated bacillus Calmette-Guérin infection: a French national retrospective study.
Casanova JL; Blanche S; Emile JF; Jouanguy E; Lamhamedi S; Altare F; Stéphan JL; Bernaudin F; Bordigoni P; Turck D; Lachaux A; Albertini M; Bourrillon A; Dommergues JP; Pocidalo MA; Le Deist F; Gaillard JL; Griscelli C; Fischer A
Pediatrics; 1996 Oct; 98(4 Pt 1):774-8. PubMed ID: 8885960
[TBL] [Abstract][Full Text] [Related]
15. Assessing the impact of different BCG vaccination strategies on severe childhood TB in low-intermediate prevalence settings.
Manissero D; Lopalco PL; Levy-Bruhl D; Ciofi Degli Atti ML; Giesecke J
Vaccine; 2008 Apr; 26(18):2253-9. PubMed ID: 18400344
[TBL] [Abstract][Full Text] [Related]
16. Tuberculosis case finding for vaccine trials in young children in high-incidence settings: a randomised trial.
Moyo S; Verver S; Hawkridge A; Geiter L; Hatherill M; Workman L; Ontong C; Msemburi W; Tameris M; Geldenhuys H; Mulenga H; Snowden MA; Hanekom WA; Hussey G; Mahomed H;
Int J Tuberc Lung Dis; 2012 Feb; 16(2):185-91. PubMed ID: 22236918
[TBL] [Abstract][Full Text] [Related]
17. Bovine TB and the development of new vaccines.
Hope JC; Villarreal-Ramos B
Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):77-100. PubMed ID: 17764740
[TBL] [Abstract][Full Text] [Related]
18. The effect of Bacille Calmette-Guérin vaccine on tuberculin reactivity in indigenous children from communities with high prevalence of tuberculosis.
Araujo Z; de Waard JH; de Larrea CF; Borges R; Convit J
Vaccine; 2008 Oct; 26(44):5575-81. PubMed ID: 18723065
[TBL] [Abstract][Full Text] [Related]
19. Determining causes of mortality in children enrolled in a vaccine field trial in a rural area in the Western Cape Province of South Africa.
Moyo S; Hawkridge T; Mahomed H; Workman L; Minnies D; Geiter LJ; Verver S; Kibel M; Hussey GD
J Paediatr Child Health; 2007 Mar; 43(3):178-83. PubMed ID: 17316193
[TBL] [Abstract][Full Text] [Related]
20. Targeted BCG vaccination against severe tuberculosis in low-prevalence settings: epidemiologic and economic assessment.
Altes HK; Dijkstra F; Lugnèr A; Cobelens F; Wallinga J
Epidemiology; 2009 Jul; 20(4):562-8. PubMed ID: 19295437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
